Evidence map›Paper›PMID 21541314›Full record

ArticlePloS one2011

Glucose and fatty acids synergize to promote B-cell apoptosis through activation of glycogen synthase kinase 3β independent of JNK activation.

Katsuya Tanabe, Yang Liu, Syed D Hasan, Sara C Martinez, Corentin Cras-Méneur, Cris M Welling, Ernesto Bernal-Mizrachi, Yukio Tanizawa, Christopher J Rhodes, Erik Zmuda and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Interorgan Crosstalk Contributing toJournal of diabetes research · 2017
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Endoplasmic reticulum stress and type 2 diabetes.Annual review of biochemistry · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Katsuya TanabeDivision of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Yang Liu
Syed D Hasan
Sara C Martinez
Corentin Cras-Méneur
Cris M Welling
Ernesto Bernal-Mizrachi
Yukio Tanizawa
Christopher J Rhodes
Erik Zmuda
Tsonwin Hai
Nada A Abumrad
M Alan Permutt
Washington University in St. Louis · USThe Ohio State University · USUniversity of Chicago · USYamaguchi University · JP

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
FATTY ACID TRANSPORTER: REGULATION, IDENTIFICATIONR01DK033301 · NIDDK · WASHINGTON UNIVERSITY · PI ABUMRAD, NADA A. · 1986 to 2017
$5.2M
AKT/mTOR Signaling and Regulation of Cell Cycle in beta CellsR01DK073716 · NIDDK · WASHINGTON UNIVERSITY · PI BERNAL-MIZRACHI, ERNESTO · 2006 to 2022
$4.6M
MITOGENIC SIGNAL TRANSDUCTION IN PANCREATIC BETA CELLSR01DK055267 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI RHODES, CHRISTOPHER J · 1998 to 2013
$4.3M
CONTROL OF INSULIN BIOSYNTHESISR37DK016746 · NIDDK · WASHINGTON UNIVERSITY · PI PERMUTT, MARSHALL ALAN · 1986 to 2007
$3.9M
CONTROL OF INSULIN BIOSYNTHESISR01DK016746 · NIDDK · WASHINGTON UNIVERSITY · PI URANO, FUMIHIKO · 1994 to 2012
$1.6M
ATF3 and iNOS in Islet Distruction and Graft RejectionR01DK064938 · NIDDK · OHIO STATE UNIVERSITY · PI HAI, TSONWIN · 2006 to 2010
$1.1M
NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30DK056341NIDDK NIH HHS P60 DK020579NIDDK NIH HHS P60 DK20579NIDDK NIH HHS R01 DK016746NIDDK NIH HHS R01 DK033301NIDDK NIH HHS R01 DK055267NIDDK NIH HHS R01 DK064938NIDDK NIH HHS R01 DK073716NIDDK NIH HHS R01 DK33301NIDDK NIH HHS R01 DK64938NIDDK NIH HHS R37 DK016746NIDDK NIH HHS R37 DK16746
6 · The paper itself

Abstract

backgroundThe combination of elevated glucose and free-fatty acids (FFA), prevalent in diabetes, has been suggested to be a major contributor to pancreatic β-cell death. This study examines the synergistic effects of glucose and FFA on β-cell apoptosis and the molecular mechanisms involved. Mouse insulinoma cells and primary islets were treated with palmitate at increasing glucose and effects on apoptosis, endoplasmic reticulum (ER) stress and insulin receptor substrate (IRS) signaling were examined. PRINCIPAL

findingsIncreasing glucose (5-25 mM) with palmitate (400 µM) had synergistic effects on apoptosis. Jun NH2-terminal kinase (JNK) activation peaked at the lowest glucose concentration, in contrast to a progressive reduction in IRS2 protein and impairment of insulin receptor substrate signaling. A synergistic effect was observed on activation of ER stress markers, along with recruitment of SREBP1 to the nucleus. These findings were confirmed in primary islets. The above effects associated with an increase in glycogen synthase kinase 3β (Gsk3β) activity and were reversed along with apoptosis by an adenovirus expressing a kinase dead Gsk3β. CONCLUSIONS/SIGNIFICANCE: Glucose in the presence of FFA results in synergistic effects on ER stress, impaired insulin receptor substrate signaling and Gsk3β activation. The data support the importance of controlling both hyperglycemia and hyperlipidemia in the management of Type 2 diabetes, and identify pancreatic islet β-cell Gsk3β as a potential therapeutic target.

Indexed as

Activating Transcription Factor 3AnimalsApoptosisCell LineEndoplasmic ReticulumEnzyme ActivationGlucoseGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaInsulinInsulin Receptor Substrate ProteinsInsulin-Secreting CellsJNK Mitogen-Activated Protein KinasesMaleMiceMice, Inbred C57BLActivating Transcription Factor 3Atf3 protein, mouseGlucoseGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, mouseInsulinInsulin Receptor Substrate ProteinsIrs2 protein, mouseJNK Mitogen-Activated Protein KinasesPalmitic AcidSrebf1 protein, mouseSterol Regulatory Element Binding Protein 1

Identifiers

PMID21541314
PMCPMC3082528
OpenAlexW2064705042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.